Wikidata

(Q64187850)

English

ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)

clinical trial

In more languages

Statements

title
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias (English)
0 references
country
Australia
0 references
Belgium
0 references
Bulgaria
0 references
Canada
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Italy
0 references
Japan
0 references
Mexico
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Taiwan
0 references
United Kingdom
0 references
start time
16 November 2017
0 references
end time
31 January 2019
0 references
number of participants
94
0 references
minimum age
12 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64187850&oldid=1857609693"